Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Jitka Komrsková"'
Publikováno v:
Listy klinicke logopedie, Vol 6, Iss 1, Pp 10-16 (2022)
We introduce the application of alternative and augmentative communication aids in children with combined disabilities and symptomatic speech disorders. We will briefly introduce and compare alternative routes of communication in two boys with develo
Externí odkaz:
https://doaj.org/article/b69e4728e6264c79858d236cf097598a
Autor:
Janka Franeková, Marek Protuš, Eva Kieslichová, Aleš Březina, Jitka Komrsková, Jiří Vymětalík, Antonín Jabor
Publikováno v:
Mediators of Inflammation, Vol 2021 (2021)
Sepsis biomarkers change continuously during the postoperative period. We aimed to demonstrate the influence of immunosuppressants after transplantation (Tx) on presepsin, procalcitonin, CRP, white blood cells, and IL-6. A group of 140 patients after
Externí odkaz:
https://doaj.org/article/8f5bb358f5cd4000b8c11be971451d01
Autor:
Zdenek Kubíček, Janka Franeková, Jiří Vymětalík, Tereza Vacková, Antonín Jabor, Jitka Komrsková
Publikováno v:
Annals of Clinical Biochemistry: International Journal of Laboratory Medicine. 56:381-386
Background Fibroblast growth factor 23 (FGF23), a potent regulator of phosphate and vitamin D metabolism, is a new biomarker of kidney, bone and cardiovascular disorders. The aim of this study was to assess the biological variation of intact fibrobla
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ae956bc327b6f21739cdc6cdc9906d1c
https://doi.org/10.1177/0004563219826161
https://doi.org/10.1177/0004563219826161
Autor:
Tereza Vacková, Zdenek Kubíček, Jitka Komrsková, Marek Protuš, Janka Franeková, Antonín Jabor
Publikováno v:
Clinica chimica acta; international journal of clinical chemistry. 521
Background Proprotein convertase subtilisin/kexin type 9 (PCSK9) is involved in the regulation of LDL receptors. Inhibition of PCSK9 increase uptake of LDL-particles and pathogen-associated molecular patterns (PAMPs). The aim of our study was to eval
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dd2ea94daa872fbe15e44baa6b8401a1
https://pubmed.ncbi.nlm.nih.gov/34153278
https://pubmed.ncbi.nlm.nih.gov/34153278
Autor:
Aleš Březina, Jitka Komrsková, Marek Protuš, Janka Franeková, Jiří Vymětalík, Eva Kieslichova, Antonín Jabor
Publikováno v:
Mediators of Inflammation
Mediators of Inflammation, Vol 2021 (2021)
Mediators of Inflammation, Vol 2021 (2021)
Sepsis biomarkers change continuously during the postoperative period. We aimed to demonstrate the influence of immunosuppressants after transplantation (Tx) on presepsin, procalcitonin, CRP, white blood cells, and IL-6. A group of 140 patients after
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f3bee8ac6a7db5ed1287966140e58824
http://europepmc.org/articles/PMC7811562
http://europepmc.org/articles/PMC7811562
Publikováno v:
Gastroenterologie a hepatologie. 70:138-140
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05727394b4e220d261bc8bc2bc3a835c
https://doi.org/10.14735/amgh2016138
https://doi.org/10.14735/amgh2016138
Autor:
Jiří Vymětalík, Jitka Komrsková, Tereza Vacková, Zdenek Kubíček, Janka Franeková, Peter Sečník, Antonín Jabor
Publikováno v:
Clinica Chimica Acta. 486:311-312
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::50ab2aa83c8dafdf22180a5fc92d0e28
https://doi.org/10.1016/j.cca.2018.08.023
https://doi.org/10.1016/j.cca.2018.08.023
Autor:
Josef Cindr, Petra Lavríková, Věra Lánská, Janka Franeková, Jitka Komrsková, Peter Sečník, Antonín Jabor
Publikováno v:
Journal of Clinical Laboratory Analysis. 32:e22432
BACKGROUND: Cancer prevention is essential after transplantation (Tx). The use of HE4 and Risk of Ovarian Malignancy Algorithm (ROMA) is recommended as a tool for selective ovarian cancer screening; however, creatinine is a known confounder. This stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58f2924d1439b3c0f11469ee781ed2ea
https://doi.org/10.1002/jcla.22432
https://doi.org/10.1002/jcla.22432